Please note: The University of Texas Health Science Center at San Antonio will now be called "UT Health San Antonio."

A Potential Vaccine for Chlamydia

← Previous entry Next entry →

Author: Charlotte Anthony | Category: In The News | February 19, 2018

Dr. Guangming Zhong and his team have found that the site of first chlamydia exposure can make all the difference when it comes to patient outcomes.

Initial exposure to chlamydia in the gut was shown to result in robust transmucosal immunity, with the lungs and genital tract protected against the disease. However, if an individual’s initial exposure to the bacteria occurs within the genital tract, it can result in a more severe disease pattern that promotes further disease, according to the official press release.

“This research emphasizes the pre-exposure of chlamydia to the gastrointestinal tract as a vaccine,” Guangming Zhong, MD, PhD, professor in the Joe R. & Teresa Lozano Long School of Medicine at UT Health San Antonio stressed in the press release.

For their study, published in the journal Infection and Immunity, they used a mouse model to better understand chlamydia transmission.

His work has been highlighted on Kens5, ContagionLive, DeccanChronicle, and many other news outlets. 

Copyright © 2019 The University of Texas Health Science Center at San Antonio

Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.

← Previous entry Next entry →

comments powered by Disqus